Immunotherapy for Stomach Cancer in India: Who Benefits, Options and Cost
Quick answer: Immunotherapy is used in some patients with advanced stomach (gastric) cancer and cancer of the gastro-esophageal junction. Checkpoint inhibitors such as nivolumab and pembrolizumab are given together with chemotherapy in selected patients, and they play a particular role in tumours with certain biomarkers, including PD-L1 expression, HER2 status and MSI-high/dMMR. Whether it applies to you depends on your pathology report, stage and general health.
Stomach cancer is often found at an advanced stage, and families understandably search for every option. This guide explains how immunotherapy fits in and which questions to take to your oncologist.
Biomarkers that guide the decision
- PD-L1: a protein measured on the tumour and immune cells. Higher scores have been linked with greater benefit from checkpoint inhibitors plus chemotherapy.
- HER2: if the tumour is HER2-positive, treatment may combine HER2-targeted therapy with chemotherapy, and in some settings immunotherapy as well.
- MSI-high or dMMR: tumours with this feature tend to respond well to checkpoint inhibitors.
These tests are carried out at your hospital or pathology laboratory, not at Denvax. Ask your treating team for the full pathology report and bring a copy to your consultation.
Immunotherapy options for stomach cancer
Checkpoint inhibitors with chemotherapy
In clinical studies of advanced gastric and gastro-esophageal junction cancers, adding a checkpoint inhibitor to first-line chemotherapy improved outcomes for patients whose tumours had higher PD-L1 scores. Approved uses and labels in India are set by CDSCO and can change, so confirm the current position with your oncologist. For a broader view of the drugs, see approved medicines for stomach cancer and our list of checkpoint inhibitors in India.
Personalised cell-based therapy
Denvax offers dendritic cell therapy as part of an individual plan that sits alongside standard treatment. Evidence in stomach cancer is still limited, and our doctors will talk through what is known and unknown before you decide. Learn more in our dendritic cell therapy guide.
Who may be considered?
- People with advanced, recurrent or metastatic gastric or gastro-esophageal junction cancer
- Patients with biomarker results that support immunotherapy (PD-L1, MSI-H/dMMR)
- Patients with stable enough health, including nutrition, to receive treatment
- Families seeking a second opinion after standard options have been explained
Our eligibility guide explains how doctors assess whether immunotherapy is suitable.
Side effects and nutrition
Immune-related effects can include rash, diarrhoea, thyroid problems and inflammation of organs such as the liver or lungs. Stomach cancer also affects appetite and weight, so nutrition support is part of care. Report new symptoms early; most immune side effects are easier to manage when caught in time.
What does it cost in India?
Costs vary with the drug, dose, number of cycles, chemotherapy combination and hospital charges. Ask for a cycle-wise estimate and clarify what is included. Our immunotherapy cost overview and financial assistance guide can help you plan.
Frequently asked questions
Can immunotherapy treat stomach cancer?
It can be part of treatment for selected patients, usually with chemotherapy in advanced disease. It is not suitable for everyone, and outcomes vary.
What is PD-L1 CPS?
The combined positive score (CPS) is a measure of PD-L1 on tumour and immune cells. Higher CPS has been associated with more benefit from checkpoint inhibitors in studies.
Is immunotherapy used after stomach cancer surgery?
Standard care after surgery usually involves chemotherapy or chemoradiation. Your oncologist will say whether any immunotherapy use applies to your situation or a trial.
Is it painful or done in hospital?
Checkpoint inhibitors are given by drip in a day-care setting at set intervals. Most people go home the same day.
Where can I get a second opinion in Delhi?
Denvax Cancer Center at Vasant Vihar, New Delhi offers consultations to review your reports and discuss options. See how to choose an immunotherapy hospital in Delhi.
Book a consultation with a Denvax oncologist to discuss your stomach cancer treatment plan. निःशुल्क परामर्श बुक करें।
Medical review: [Reviewer name and qualifications to be added before publishing]. This article is for information and does not replace advice from your oncologist. Results may vary. Consult your oncologist.
- Cancer Treatment in India for International Patients: A Step-by-Step Guide
- Immunotherapy for Esophageal Cancer in India: Options, Eligibility and Cost
